Impressive Continuous Complete Response After Mogamulizumab in a Heavily Pre-Treated Sézary Syndrome Patient. Mediterr J Hematol Infect Dis 2020, 12 (1), e2020040. https://doi.org/10.4084/mjhid.2020.040.